Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of Saskatchewan

$25,000.00

Development of new methodologies for heterocyclic and chiral building block synthesis

EF 2012-13

Résumé
The use of heterocyclic and chiral building blocks is central to the practice of medicinal chemistry. These building blocks are incorporated in drug candidates for high-throughput screening in drug discovery endeavours. The current difficulties encountered by pharmaceutical companies in developing active pharmaceutical ingredients with novel, patentable structures may be overcome in part by an easier access to a wide variety of heterocyclic and chiral building blocks. TC Scientific Inc. specializes in the synthesis and commercialization of novel building blocks for the pharmaceutical and fine chemical industries. The new methodologies described in this proposal will give access to such novel building blocks. The successful development of stereoselective aza-benzoin reactions will deliver chiral alpha-amino ketones, a key structural feature in a number of approved drugs which is often difficult to access by other methods. In addition, the products from this reaction can also be rapidly cyclized to provide novel heterocyclic structures. The other type of reactions described in this proposal are Stetter reactions on beta-alkoxy-substituted acceptors. The products from these reactions display a highly oxygenated carbon chain which can be incorporated into drug frameworks directly, or cyclized to be used as heterocyclic building blocks. Thus, the goal of this project is to establish a partnership that will take advantage of expertise present at the University of Saskatchewan to provide methodologies that can be used by TC Scientific Inc. to advance their building block synthesis and commercialization capabilities.
Programme
Engage Grants Program
Emplacement
Saskatchewan, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
432443-2012
Name nom
Gravel, Michel
Department département
Chemistry
Organization id
16
Institution établissement
University of Saskatchewan
Province en
Saskatchewan
Province fr
Saskatchewan
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3700
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic chemistry
Research subject fr
Chimie organique
Partie
1
Nb partie
1
Application title
Development of new methodologies for heterocyclic and chiral building block synthesis
Keyword
NSERC
Application summary
The use of heterocyclic and chiral building blocks is central to the practice of medicinal chemistry. These building blocks are incorporated in drug candidates for high-throughput screening in drug discovery endeavours. The current difficulties encountered by pharmaceutical companies in developing active pharmaceutical ingredients with novel, patentable structures may be overcome in part by an easier access to a wide variety of heterocyclic and chiral building blocks. TC Scientific Inc. specializes in the synthesis and commercialization of novel building blocks for the pharmaceutical and fine chemical industries. The new methodologies described in this proposal will give access to such novel building blocks. The successful development of stereoselective aza-benzoin reactions will deliver chiral alpha-amino ketones, a key structural feature in a number of approved drugs which is often difficult to access by other methods. In addition, the products from this reaction can also be rapidly cyclized to provide novel heterocyclic structures. The other type of reactions described in this proposal are Stetter reactions on beta-alkoxy-substituted acceptors. The products from these reactions display a highly oxygenated carbon chain which can be incorporated into drug frameworks directly, or cyclized to be used as heterocyclic building blocks. Thus, the goal of this project is to establish a partnership that will take advantage of expertise present at the University of Saskatchewan to provide methodologies that can be used by TC Scientific Inc. to advance their building block synthesis and commercialization capabilities.